These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15109023)

  • 41. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
    Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
    J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro Methods for In vitro-In vivo Correlation (IVIVC) for Poorly Water Soluble Drugs: Lipid Based Formulation Perspective.
    Kazi M; Al Amri R; Alanazi FK; Hussain MD
    Curr Drug Deliv; 2018; 15(7):918-929. PubMed ID: 29336263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.
    Greco K; Bogner R
    J Pharm Sci; 2012 Sep; 101(9):2996-3018. PubMed ID: 22213419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of dissolution property of poorly water-soluble drug by novel dry coating method using planetary ball mill.
    Sonoda R; Horibe M; Oshima T; Iwasaki T; Watano S
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1243-7. PubMed ID: 18758094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
    Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
    Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
    [No Abstract]   [Full Text] [Related]  

  • 50. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution.
    Moribe K; Makishima T; Higashi K; Liu N; Limwikrant W; Ding W; Masuda M; Shimizu T; Yamamoto K
    Int J Pharm; 2014 Jul; 469(1):190-6. PubMed ID: 24746412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Spray Flash Evaporation (SFE) technology to improve dissolution of poorly soluble drugs: Case study on furosemide nanocrystals.
    Coty JB; Martin C; Telò I; Spitzer D
    Int J Pharm; 2020 Nov; 589():119827. PubMed ID: 32866647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Innovative processes for bio-pharmaceuticals and poorly water-soluble API".
    Müller-Goymann C; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():1. PubMed ID: 29474867
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
    Kipp JE
    Int J Pharm; 2004 Oct; 284(1-2):109-22. PubMed ID: 15454302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
    Ozeki T; Tagami T
    Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug polymorphism and dosage form design: a practical perspective.
    Singhal D; Curatolo W
    Adv Drug Deliv Rev; 2004 Feb; 56(3):335-47. PubMed ID: 14962585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
    Tay T; Allahham A; Morton DA; Stewart PJ
    J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting.
    Zhang L; Alfano J; Race D; Davé RN
    Eur J Pharm Sci; 2018 May; 117():245-254. PubMed ID: 29499350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs.
    Khan KU; Minhas MU; Badshah SF; Suhail M; Ahmad A; Ijaz S
    Life Sci; 2022 Feb; 291():120301. PubMed ID: 34999114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.